Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Histone Variants at the Centromere02:30

Histone Variants at the Centromere

5.3K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
5.3K
Human Genetics01:28

Human Genetics

2.0K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
2.0K
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

295
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
295
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

108
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
108
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

122
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
122
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

17.5K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
17.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic Improvements with a Ketogenic Diet Correlate with Symptom Improvement in Psychosis: A Randomized Controlled Trial.

Schizophrenia bulletin·2026
Same author

Converting negative symptom dimension scores across SANS and PANSS.

Schizophrenia research·2026
Same author

A primer on corollary discharges: neural signals that distinguish 'Self' from 'World'.

NPP - digital psychiatry and neuroscience·2026
Same author

Parsing Reward Processing Substages With Multimodal EEG-fMRI.

Human brain mapping·2026
Same author

Shared genetic architecture of brain age gap across 30 cohorts worldwide.

medRxiv : the preprint server for health sciences·2026
Same author

Neurophysiological Evidence of Motor Preparation Dysfunction during Inner Speech and its Association with Auditory Verbal Hallucinations in Schizophrenia Spectrum Disorders.

Schizophrenia bulletin·2025

Related Experiment Video

Updated: Apr 21, 2026

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

9.2K

Decomposing P300 to identify its genetic basis.

Judith M Ford1

  • 1San Francisco VA Medical Center, San Francisco, California, USA; Department of Psychiatry, University of California, San Francisco (UCSF), San Francisco, California, USA.

Psychophysiology
|November 13, 2014
PubMed
Summary

Linking P300 brain responses to genes is challenging. This commentary proposes decomposing P300 into its contributing factors to better understand its genetic basis and identify specific genes or single nucleotide polymorphisms (SNPs).

Keywords:
EEGGenetic basisP300 amplitudeSNPs

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.2K
Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

7.2K

Related Experiment Videos

Last Updated: Apr 21, 2026

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

9.2K
Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.2K
Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

7.2K

Area of Science:

  • Cognitive Neuroscience
  • Psychophysiology
  • Behavioral Genetics

Background:

  • The P300 event-related potential (ERP) is a widely studied neural signal.
  • Associating P300 amplitude with specific genes or single nucleotide polymorphisms (SNPs) has proven difficult.
  • The complex nature of P300 likely contributes to challenges in genetic linkage.

Purpose of the Study:

  • To explore the reasons behind the difficulty in linking P300 amplitude to genetic factors.
  • To propose a strategy for improving the genetic investigation of P300.
  • To suggest that decomposing P300 into its constituent components may facilitate genetic association studies.

Main Methods:

  • Review and theoretical discussion of P300 measurement and analysis.
  • Proposing methods to improve P300 measurement, including multiple measurement occasions.
  • Suggesting the estimation of electroencephalography (EEG) power in specific bands and adjustment for single-trial variability.
  • Recommending task refinement to isolate underlying psychological processes.

Main Results:

  • The conglomerate P300 signal is influenced by multiple underlying factors.
  • Decomposition of P300 can yield more precise measures.
  • Improved measurement techniques can reduce state-dependent contributions and single-trial variability.
  • Refined tasks can isolate specific cognitive processes reflected by P300.

Conclusions:

  • Decomposing P300 into its contributing factors is a promising approach for genetic research.
  • Each decomposed factor may serve as a distinct endophenotype.
  • These endophenotypes could potentially be mapped to specific SNPs or genes.
  • This strategy may enhance the ability to identify the genetic underpinnings of P300.